Harvard Bioscience (HBIO) EPS (Weighted Average and Diluted) Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | 31.62% |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | -39.68% |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 20.14% |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 1.25% |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | - |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 15.35% |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 11.26% |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | -32.64% |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | 10.95% |
| 10 | Harvard Bioscience | 25.38 Mn | 18.29 Mn | 12.24 Mn | -328.26% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -328.26% |
| Dec 31, 2025 | -13.59% |
| Jun 30, 2023 | 20.63% |
| Mar 31, 2023 | 27.72% |
| Dec 31, 2022 | -66.46% |
| Jun 30, 2022 | 100.00% |
| Mar 31, 2022 | -41.50% |
| Jun 30, 2021 | 37.00% |
| Jun 30, 2020 | -58.74% |
| Mar 31, 2020 | -81.71% |
| Dec 31, 2019 | 35.72% |
| Sep 30, 2019 | -11.87% |
| Jun 30, 2019 | 20.63% |
| Mar 31, 2019 | -44.22% |
| Dec 31, 2018 | 29.59% |
| Sep 30, 2018 | 20.63% |
| Jun 30, 2018 | -81.71% |
| Mar 31, 2018 | -40.10% |
| Sep 30, 2017 | -35.72% |
| Jun 30, 2017 | -32.64% |
| Mar 31, 2017 | -44.22% |
| Dec 31, 2016 | -58.74% |
| Sep 30, 2016 | -18.56% |
| Jun 30, 2016 | -31.00% |
| Mar 31, 2016 | 8.80% |
| Dec 31, 2015 | -145.24% |
| Sep 30, 2015 | -25.99% |
| Jun 30, 2015 | -20.63% |
| Mar 31, 2015 | -58.74% |
| Sep 30, 2014 | 177.33% |
| Jun 30, 2014 | -15.66% |
| Mar 31, 2014 | -30.66% |
| Dec 31, 2013 | -28.56% |
| Sep 30, 2013 | -27.41% |
| Jun 30, 2013 | -29.03% |